Earnings History Data for ASLAN Pharmaceuticals Limited (ASLN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited operates as a clinical-stage biotechnology company. It develops drugs, medicines and novel therapeutics for the treatment of patients with oncology, respiratory and inflammatory diseases. The company's product portfolio includes Varlitinib, ASLAN004, ASLAN002 and ASLAN003 both are in clinical stage. ASLAN Pharmaceuticals Limited is based in Singapore.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-04-2023	PM	7:00 AM ET (Apr 28)	ASLN	ASLAN Pharmaceuticals	59.00	-1.29	-0.80	0.00	ASLAN Pharmaceuticals GAAP EPS of -$1.29 misses by $0.86 [4/28/2023 7:40 AM]	4.15	-0.10 (-2.35%)	0.0	0.0 (0.00%)	1.70 - 4.94	41,347	40,000	0
ASLAN Pharmaceuticals GAAP EPS of -$1.29 misses by $0.86 [4/28/2023 7:40 AM]
28-10-2022	PM		ASLN	ASLAN Pharmaceuticals	31.00	-0.16	-0.20	0.00	ASLAN Pharmaceuticals GAAP EPS of -$0.02 [10/28/2022 7:29 AM]	0.4011	0.0 (0.53%)	0.42	0.02 (5.76%)	0.36 - 1.91	117,410	200,000	100
ASLAN Pharmaceuticals GAAP EPS of -$0.02 [10/28/2022 7:29 AM] ASLAN Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Oct-28-22 07:00AM]
27-04-2022	PM		ASLN	ASLAN Pharmaceuticals	49.00	-0.19	-0.17	0.00	ASLAN Pharmaceuticals GAAP EPADS of -$0.19 misses by $0.01 [4/27/2022 7:51 AM]	0.6706	-0.03 (-4.19%)	0.0	0.0 (0.00%)	0.66 - 3.87	138,767	150,000	0
ASLAN Pharmaceuticals GAAP EPADS of -$0.19 misses by $0.01 [4/27/2022 7:51 AM] ASLAN Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update [Apr-27-22 07:00AM]
25-03-2022	PM		ASLN	ASLAN Pharmaceuticals	33.00	-0.16	-0.15	0.00	ASLAN Pharmaceuticals GAAP EPS of -$0.03 [3/25/2022 7:24 AM]	0.8572	-0.06 (-6.77%)	0.93	0.01 (1.10%)	0.73 - 3.88	123,682	213,312	0
ASLAN Pharmaceuticals GAAP EPS of -$0.03 [3/25/2022 7:24 AM] ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-25-22 07:00AM]
26-10-2021	PM		ASLN	ASLAN Pharmaceuticals Ltd.	56.00	-0.12	-0.12	0.00	ASLAN Pharmaceuticals EPS beats by $0.08 [10/26/2021 7:23 AM]	1.51	0.13 (8.99%)	1.39	0.0 (0.00%)	1.38 - 6.75	924,819	660,000	20,574
ASLAN Pharmaceuticals EPS beats by $0.08 [10/26/2021 7:23 AM] ASLAN Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Oct-26-21 07:00AM]
06-08-2021	PM		ASLN	Aslan Pharmaceuticals Ltd.	106.00	-0.08	-0.11	0.00	ASLAN Pharmaceuticals EPS misses by $0.02 [8/6/2021 7:27 AM]	2.98	0.03 (1.02%)	2.98	0.03 (1.02%)	1.26 - 6.75	696,956	400,000	3,562
ASLAN Pharmaceuticals EPS misses by $0.02 [8/6/2021 7:27 AM] ASLAN Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-06-21 07:00AM]
11-05-2021	PM	7:50 AM ET (May 11)	ASLN	ASLAN Pharmaceuticals Limited	217.60	-0.13	-0.11	-0.08	ASLAN Pharmaceuticals reports Q1 results [5/11/2021 8:09 AM]	2.75	-0.08 (-2.83%)	2.76	-0.07 (-2.47%)	1.26 - 6.75	388,246	270,000	7,303
ASLAN Pharmaceuticals reports Q1 results [5/11/2021 8:09 AM] Epizyme's (EPZM) Q1 Earnings Miss, Revenues Beat Estimates [May-07-21 07:24AM] ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-11-21 07:30AM]
22-04-2021	PM		ASLN	Aslan Pharmaceuticals Ltd.	108.00	-0.15	-0.11	0.00	ASLAN Pharmaceuticals EPS beats by $0.04 [4/22/2021 7:59 AM]	3.02	0.03 (1.00%)	3.00	0.01 (0.33%)	1.26 - 6.75	1,321,577	410,000	10,201
ASLAN Pharmaceuticals EPS beats by $0.04 [4/22/2021 7:59 AM] ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Apr-22-21 07:51AM]